{"doi":"10.1016/j.jtho.2023.09.1185","title":"EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study","abstract":null,"journal":"Journal of Thoracic Oncology","year":2023,"id":611558,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1573975,"name":"E. Carcereny","orcid":null,"position":1,"is_corresponding":false},{"id":1573976,"name":"A. Padilla","orcid":null,"position":2,"is_corresponding":false},{"id":1573977,"name":"J.M. Rodríguez García","orcid":null,"position":3,"is_corresponding":false},{"id":1573978,"name":"J.F. Córdoba","orcid":null,"position":4,"is_corresponding":false},{"id":1573979,"name":"E. Esteban","orcid":null,"position":5,"is_corresponding":false},{"id":1573980,"name":"C. Aguado","orcid":null,"position":6,"is_corresponding":false},{"id":1573981,"name":"J. Garde","orcid":null,"position":7,"is_corresponding":false},{"id":1573982,"name":"A. Moreno Vega","orcid":null,"position":8,"is_corresponding":false},{"id":1573983,"name":"C. Ávila Andrade","orcid":null,"position":9,"is_corresponding":false},{"id":1573984,"name":"M. Sereno","orcid":null,"position":10,"is_corresponding":false},{"id":46697,"name":"A. Sánchez-Hernández","orcid":"0000-0001-9548-0358","position":11,"is_corresponding":false},{"id":1573985,"name":"M. López-Brea","orcid":null,"position":12,"is_corresponding":false},{"id":1573986,"name":"B. Massuti","orcid":null,"position":13,"is_corresponding":false},{"id":1573987,"name":"C. Martí Blanco","orcid":null,"position":14,"is_corresponding":false},{"id":1573988,"name":"M. Campayo","orcid":null,"position":15,"is_corresponding":false},{"id":1573989,"name":"P. Arnáiz","orcid":null,"position":16,"is_corresponding":false},{"id":1573990,"name":"D. Pérez Parente","orcid":null,"position":17,"is_corresponding":false},{"id":1573991,"name":"C.A. Fajardo","orcid":null,"position":18,"is_corresponding":false},{"id":1573992,"name":"I. Ramos","orcid":null,"position":19,"is_corresponding":false},{"id":64517,"name":"R. Álvarez","orcid":"0000-0001-8124-1700","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study","abstract":null,"is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":"https://openalex.org/W4388045576","authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"bronze","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.jto.org/article/S1556086423019871/pdf","host_type":"journal"},{"url":"http://www.jto.org/article/S1556086423019871/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1556086423019871?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1556086423019871?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.jtho.2023.09.1185","host_type":"journal"}],"fields_of_study":["Cancer Immunotherapy and Biomarkers","Multiple and Secondary Primary Cancers","Eosinophilic Esophagitis"],"mesh_terms":[],"keywords":["Atezolizumab","Medicine","Docetaxel","Oncology","Lung cancer","Internal medicine","Special populations","Nivolumab","Cancer","Immunotherapy"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-01T20:35:34.329652Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}